- Letters to the Editor
- Open Access
Serum cytokines profile of critically ill COVID-19 patients with cardiac dysfunction
Intensive Care Medicine Experimental volume 9, Article number: 2 (2021)
To the Editor,
Most patients requiring intensive care unit (ICU) admission for Coronavirus disease 2019 (COVID-19) presented acute respiratory distress syndrome (ARDS) . However, a significant proportion of critically ill COVID-19 patients developed an acute COVID-19 cardiovascular syndrome (ACovCS) characterized by acute myocardial injury, evidenced by an increase in circulating biomarkers including serum troponin and B-type natriuretic peptide, associated with elevated interleukin-6 concentrations, myocardial dysfunction, ventricular arrhythmias, circulatory insufficiency and a high mortality rate [2, 3]. The pathophysiology of ACovCS remains unclear. Infection by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) seems to trigger peculiar innate and adaptive immune responses. High concentrations of circulating cytokines involved in the innate immune response , have been associated with poor outcomes in COVID-19 patients. We aimed at evaluating whether critically ill COVID-19 patients with cardiac dysfunction exhibited a peculiar immunological phenotype.
Here, we report on clinical and echocardiographic features together with serum levels of cytokines in a monocenter prospective study of critically ill COVID-19 patients admitted to the medical ICU of Henri Mondor Hospital, Créteil, France, between March 8th and March 30th, 2020. The study has received the approbation of an institutional review board (Comité de Protection des Personnes Ile de France II; reference number: 3675-NI). Informed consent was obtained from all patients or their relatives. Reverse-transcriptase polymerase chain reaction (RT-PCR) assays of nasopharyngeal swabs were positive for SARS-CoV-2 in all patients. Blood samples were drawn within 48 h of ICU admission to measure cytokines concentrations using Luminex® multiplex bead-based technology (R&D Systems, Minneapolis, MN, USA) on serum diluted ½. Echocardiographies were performed within the same time frame to characterize cardiac dysfunction (see supplemental method section) and categorize patients according to LVEF tertiles. Patients were not receiving dobutamine at the time the first echocardiography was performed, except for one patient. Principal component analysis (PCA) was used to summarize cytokines profiles information and assess its relation with LVEF tertiles (see Additional file 1 for a detailed description of the statistical methods).
Additional file 2: Table S1 shows the characteristics of the 34 consecutive patients included in this study cohort, four of whom had previously known moderate LVEF dysfunction (i.e., between 35 and 50%). The first plan of the PCA accounted for 46.2% of inertia, thus almost half the total variance or inertia, and was mainly driven, among the 19 serum cytokine assays, by three of them, involved in the innate immune response (i.e., IL-10, GM-CSF and CXCL10/IP-10), which were highly correlated between each other and thus formed a coherent cytokine group (Fig. 1a). Moreover, this data partitioning built on the immunological phenotyping at ICU admission was significantly, and independently, connected to LVEF tertiles categorization (Fig. 1b) (tertile 1: hypokinetic patients, LVEF between 28 and 55%; tertile 2: normokinetic patients, LVEF 55–67%; tertile 3: hyperkinetic patients, LVEF 67–80%), indicating that patients with different values of LVEF had contrasted serum cytokines profiles.
We herein showed that there were three distinct serum cytokines patterns according to cardiac function, as assessed by LVEF, in critically ill COVID-19 patients. Interestingly, LVEF tertiles were also significantly associated with blood troponin levels (Additional file 3: Fig S1), highlighting a global association between serum cytokines profiles, cardiac dysfunction and troponin elevation. The finding of an IP-10, IL-10, and GM-CSF signature highlights the contribution of myeloid cells to pathogenic inflammation, as previously reported . Such inflammation may amplify an auto-inflammatory loop leading not only to lung, but also myocardial, injury. Further studies, including myocardial tissue and cardiac magnetic resonance studies, are needed to assess the contribution of associated acute myocarditis lesions. Our study highlights the potentially pathogenic association between serum cytokines profiles and myocardial injury in critically ill COVID-19 patients. However, because up to 29% of patients with severe SARS-CoV-2 infection and cardiac dysfunction have a history of coronary heart disease , we cannot exclude that a substantial proportion of our patients had a previously unknown heart failure. Our study has a number of limitations related to the small number of patients included and the lack of a non-COVID-19 control group, making the results only exploratory. In conclusion, our results establish a link between serum cytokines profiles and LVEF in patients with severe SARS-CoV-2 infection, but do not allow for causal inferences to be drawn regarding the mechanisms at play.
Availability of data and materials
All data generated and analyzed during the study are included in the published article and can be shared upon request. All authors helped to revise the draft of the manuscript. All authors read and approved the final manuscript.
The study has received the approbation of an institutional review board (Comité de Protection des Personnes Ile de France II; reference number: 3675-NI). Informed consent was obtained from all patients or their relatives.
Intensive care units
Coronavirus disease 2019
Acute respiratory distress syndrome
Acute COVID-19 cardiovascular syndrome
Severe acute respiratory syndrome coronavirus 2
Left ventricle ejection fraction
Reverse-transcriptase polymerase chain reaction
Principal component analysis
Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan China. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994
Hendren NS, Drazner MH, Bozkurt B, Cooper LT (2020) Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation 141:1903–1914. https://doi.org/10.1161/CIRCULATIONAHA.120.047349
Li X, Pan X, Li Y et al (2020) Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review. Crit Care Lond Engl 24:468. https://doi.org/10.1186/s13054-020-03183-z
Ruan Q, Yang K, Wang W et al (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46:846–848. https://doi.org/10.1007/s00134-020-05991-x
Hue S, Beldi-Ferchiou A, Bendib I et al (2020) Uncontrolled innate and impaired adaptive immune responses in patients with COVID-19 ARDS. Am J Respir Crit Care Med. https://doi.org/10.1164/rccm.202005-1885OC
Shi S, Qin M, Shen B et al (2020) Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 5:802–810. https://doi.org/10.1001/jamacardio.2020.0950
We are very indebted to all physicians and nurses of Henri Mondor medical Intensive Care Unit for their good hand in providing care to COVID-19 patients.
The present study has been conducted without any financial support.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Clinical characteristics of 34 critically ill COVID-19 patients, according to left ventricle ejection fraction (LVEF) tertiles.
Serum troponin concentrations as a function of tertiles of left ventricle ejection fraction (LVEF) in critically ill COVID-19 patients.
About this article
Cite this article
Bagate, F., Maziers, N., Hue, S. et al. Serum cytokines profile of critically ill COVID-19 patients with cardiac dysfunction. ICMx 9, 2 (2021). https://doi.org/10.1186/s40635-021-00368-w